Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of Xyntha in Chinese Subjects with Hemophilia A
NCT02461992Phase 1Completed
- Sponsor
- Pfizer
- Start
- Jul 2015
- Primary completion
- Aug 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of moroctocog alfa in hemophilia A, sponsored by Pfizer. Primary endpoints: Maximum Plasma FVIII Activity, Area Under the Plasma FVIII Activity-Time Profile and 7 more. Started Jul 2015; status: completed.
02
Drugs
moroctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT02461992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02461992.